ATE183641T1 - Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen - Google Patents

Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen

Info

Publication number
ATE183641T1
ATE183641T1 AT94906994T AT94906994T ATE183641T1 AT E183641 T1 ATE183641 T1 AT E183641T1 AT 94906994 T AT94906994 T AT 94906994T AT 94906994 T AT94906994 T AT 94906994T AT E183641 T1 ATE183641 T1 AT E183641T1
Authority
AT
Austria
Prior art keywords
pct
medicinal forms
controlled release
excipients
sec
Prior art date
Application number
AT94906994T
Other languages
English (en)
Inventor
Giuseppe Motta
Original Assignee
Saitec Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT000455 external-priority patent/IT1260242B/it
Priority claimed from ITBO930294A external-priority patent/IT1263445B/it
Priority claimed from IT93BO000460A external-priority patent/IT1268454B1/it
Application filed by Saitec Srl filed Critical Saitec Srl
Application granted granted Critical
Publication of ATE183641T1 publication Critical patent/ATE183641T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94906994T 1992-12-23 1993-12-23 Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen ATE183641T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000455 IT1260242B (it) 1992-12-23 1992-12-23 Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenute.
ITBO930294A IT1263445B (it) 1993-06-24 1993-06-24 Procedimento per preparare forme farmaceutiche a rilascio controllato/ritardato del principio attivo e le forme farmaceutiche cosi' ottenute
IT93BO000460A IT1268454B1 (it) 1993-11-12 1993-11-12 Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.

Publications (1)

Publication Number Publication Date
ATE183641T1 true ATE183641T1 (de) 1999-09-15

Family

ID=27273889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94906994T ATE183641T1 (de) 1992-12-23 1993-12-23 Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen

Country Status (14)

Country Link
US (1) US5662935A (de)
EP (1) EP0675710B1 (de)
JP (1) JP3459421B2 (de)
KR (1) KR100297541B1 (de)
AT (1) ATE183641T1 (de)
AU (1) AU683044B2 (de)
BR (1) BR9307736A (de)
CA (1) CA2151396C (de)
DE (1) DE69326163T2 (de)
DK (1) DK0675710T3 (de)
ES (1) ES2138070T3 (de)
GR (1) GR3031936T3 (de)
RU (1) RU2128499C1 (de)
WO (1) WO1994014421A2 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
IT1292588B1 (it) * 1997-05-28 1999-02-08 Saitec Srl Procedimento per preparare forme alimentari ad elevata resa di sapore e le forme alimentari cosi' ottenute.
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
SG98393A1 (en) 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
US7201891B1 (en) * 2000-05-19 2007-04-10 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
WO2002013792A1 (fr) * 2000-08-11 2002-02-21 Eisai Co., Ltd. Dispersion solide médicamenteuse à solubilité accrue
DE10114245A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
BR0102252B1 (pt) * 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
RU2330642C2 (ru) * 2001-07-06 2008-08-10 Лайфсайкл Фарма А/С Регулируемая агломерация
IS6390A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka sem í eru örholrými, þannig húðuðum skrokkum og einnig af notkunþeirra
ITBO20020094A1 (it) 2002-02-22 2003-08-22 Tecnea Engineering S R L Procedimento per la realizzazione di composizioni ed apparecchiatura realizzante tale procedimento
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20060153908A1 (en) * 2002-06-27 2006-07-13 Brian Strong Spherical pellet formulations
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
UA87471C2 (uk) * 2003-09-03 2009-07-27 Фарматон С.А. Капсули, які містять пелети з діючими речовинами, які відрізняються між собою профілями вивільнення з них діючих речовин
WO2005049306A1 (en) * 2003-11-18 2005-06-02 Eurand Pharmaceuticals Limited Ultrasound-assisted compaction process with a compaction device made of coupled plastic-metal materials
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005024171A1 (de) * 2005-03-22 2006-09-28 Grünenthal GmbH Verfahren und Vorrichtung zur Ultraschallverpressung einer Tablette oder einer multipartikulären Arzneiform
RU2308915C2 (ru) * 2005-10-31 2007-10-27 Александр Николаевич Епихин Способ разрушения и удаления внутренних сред глаза - высокоскоростная механогидроэмульгация
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US20100037713A1 (en) * 2007-03-08 2010-02-18 Vijay Mohan Iyer Pharmaceutical Analysis Apparatus and Method
RU2343886C1 (ru) * 2007-03-19 2009-01-20 Александр Николаевич Епихин Способ выбора параметров гидродинамического воздействия, используемого для разрушения хрусталика глаза
RU2351352C2 (ru) * 2007-04-09 2009-04-10 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Твердая нанокомпозиция для доставки биологически активных веществ
AU2009207796B2 (en) 2008-01-25 2014-03-27 Grunenthal Gmbh Pharmaceutical dosage form
KR101690094B1 (ko) 2008-05-09 2016-12-27 그뤼넨탈 게엠베하 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
CA2765971C (en) 2009-07-22 2017-08-22 Gruenenthal Gmbh Hot-melt extruded controlled release dosage form
PL2611425T3 (pl) 2010-09-02 2014-09-30 Gruenenthal Gmbh Odporna na ingerencję postać dawki zawierająca polimer anionowy
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
PL2736495T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
HRP20171458T1 (hr) 2011-07-29 2017-11-17 Grünenthal GmbH Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
WO2013127831A1 (en) 2012-02-28 2013-09-06 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
LT2838512T (lt) 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AR096438A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014321277B2 (en) 2013-09-19 2017-07-20 Terumo Corporation Polymer particles
KR102505172B1 (ko) 2013-09-19 2023-02-28 마이크로벤션, 인코포레이티드 중합체 필름
WO2015070094A1 (en) 2013-11-08 2015-05-14 Microvention, Inc. Polymer particles
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
JP2017518980A (ja) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールを含む、改変防止即時放出カプセル製剤
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
KR20170139158A (ko) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
KR102162370B1 (ko) 2016-09-28 2020-10-06 테루모 가부시키가이샤 중합체 입자

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US3078216A (en) * 1961-04-11 1963-02-19 American Cyanamid Co Prolonged release oral pharmaceutical preparations
US3137630A (en) * 1961-06-09 1964-06-16 Eastman Kodak Co Process for preparing a dry, finely divided, gelatin particle product
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
BR6457270D0 (pt) * 1963-03-04 1973-09-20 Merck & Co Inc Processo de preparacao de uma composicao farmaceutica provendo uma liberacao prolongada de uma droga no aparelho gastro intestinal
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3822252A (en) * 1968-06-28 1974-07-02 Schering Corp 3-azetidinols
FR2096292A5 (de) * 1970-06-15 1972-02-11 Sumitomo Chemical Co
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
JPS6094403A (ja) * 1983-10-27 1985-05-27 Nippon Sangaria Bebaretsuji Co:Kk 超音波を利用した粉末製剤の製造方法
US4657543A (en) * 1984-07-23 1987-04-14 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
US4779806A (en) * 1984-07-23 1988-10-25 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base
ATE124422T1 (de) * 1989-04-12 1995-07-15 Procter & Gamble Festes verbraucherprodukt, welches feinteilige cyclodextrin-komplexe enthält.
JP2958103B2 (ja) * 1989-12-12 1999-10-06 エーザイ株式会社 プラズマ照射固形製剤
JPH03287544A (ja) * 1990-04-05 1991-12-18 Biomaterial Universe Kk 生体分解吸収性高分子材料を用いた徐放性薬剤
FR2664851B1 (fr) * 1990-07-20 1992-10-16 Oreal Procede de compactage d'un melange pulverulent permettant d'obtenir un produit compact absorbant ou partiellement delitable et produit obtenu par ce procede.
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
CA2151396C (en) 2006-08-22
JPH08504807A (ja) 1996-05-28
JP3459421B2 (ja) 2003-10-20
DE69326163T2 (de) 2000-05-04
AU6043494A (en) 1994-07-19
WO1994014421A2 (en) 1994-07-07
KR960700043A (ko) 1996-01-19
RU2128499C1 (ru) 1999-04-10
AU683044B2 (en) 1997-10-30
DK0675710T3 (da) 2000-03-27
EP0675710B1 (de) 1999-08-25
DE69326163D1 (de) 1999-09-30
WO1994014421A3 (en) 1994-08-18
BR9307736A (pt) 1999-08-31
GR3031936T3 (en) 2000-03-31
US5662935A (en) 1997-09-02
CA2151396A1 (en) 1994-07-07
ES2138070T3 (es) 2000-01-01
KR100297541B1 (ko) 2001-11-26
EP0675710A1 (de) 1995-10-11

Similar Documents

Publication Publication Date Title
ATE183641T1 (de) Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
ATE147261T1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
PL315181A1 (en) Method of producing pharmaceutical doses of hydrophobous substances in solid form
ATE129406T1 (de) Rotogranulate und geschmacksabdeckende überzüge zur herstellung pharmazeutischer kautabletten.
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
ATE23110T1 (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung.
NO960067D0 (no) Nytt farmasöytisk preparat
ATE136459T1 (de) Verfahren zur herstellung retardierter arzneimittelzubereitungen
HU9501953D0 (en) Pharmaceutically active pyridine derivatives and process for the preparation thereof
DK0789559T4 (da) Farmaceutisk præparat indeholdende en smeltelig bærer og en fremgangsmåde til fremstilling deraf
DE69936430D1 (de) Verfahren zur Herstellung von in der Mundhöhle rasch zerfallenden Tabletten
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
HUT63954A (en) Process for producing active ingredient containing microparticldes from hydrolytically degredable polymers
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
IL112802A0 (en) Film coated tablets of paracetamol and domperidone and their preparation
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
NO974838D0 (no) Fremgangsmåte for fremstilling av formlegemer
HUT34344A (en) Process for producing tablets controlled dissolution of active ingredients
DE69427648D1 (de) Verfahren zur herstellung einer clodronat-zubereitung
DE59005781D1 (de) Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
AT399504B (de) Neue aminopropoxyimino-cycloalkanderivate, deren herstellung, arzneimittel, die diese verbindungen als wirkstoff enthalten sowie verfahren zur herstellung derselben
HUT53891A (en) Nematocide insecticide and acaricide comprising 5-substituted-3-arylisoxazole derivatives as active ingredient and process for producing the active ingredients
KR790000794B1 (en) Process for preparing solid medicament

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee